Why Do Hospital Stocks Continue to Attract Funds in 2568?
Many investors are re-evaluating the healthcare sector. This is no coincidence—along with the accelerating aging population in Thailand, rising public demand for quality medical services, and the emergence of new diseases, hospital businesses are showing steady growth momentum. Unlike other cyclical industries, ซื้อหุ้นโรงพยาบาล ( purchasing hospital stocks ) has become a key choice for building a defensive investment portfolio.
Three Main Attractions of Hospital Stocks:
Stable Cash Flow: After a one-time investment in infrastructure, daily operational income flows continuously, unlike real estate which requires ongoing development of new projects
Strong Resistance to Economic Fluctuations: Even during economic downturns, demand for medical care does not decrease, which is a characteristic of defensive stocks (Defensive Stock)
Solid Financial Foundation: Large-scale medical institutions can quickly recover investments and develop strong self-sustaining capabilities
Overview Comparison of the Top 7 Hospital Stocks in 2568
Hospital Group
Stock Code
Market Cap(Billion Baht)
Stock Price(Baht)
P/E Ratio
ROE(%)
Bangkok Hospital
BH
13.91 billion
183.00
18.34
31.91
Bangkok Medical City
BDMS
35.60 billion
23.30
22.81
16.77
Bangkok Chain Hospital
BCH
3.42 billion
14.40
23.13
11.88
Chulalongkorn Hospital
CHG
2.33 billion
2.24
20.32
15.42
Praram 9 Hospital
PR9
1.70 billion
21.30
24.47
13.57
Vibhavadi Hospital
VIBHA
2.46 billion
1.88
23.85
8.49
Chularat Health Group
THG
1.07 billion
13.50
—
-6.91
In-Depth Analysis of the 7 Hospital Stocks
Bangkok Hospital Group (BH): Market Leader
As one of Thailand’s oldest private hospitals, founded in 1984 (, BH has become a major contractor for social security programs. Latest data shows a market cap of 139,110 billion Baht, net profit of 5,871.77 billion Baht, and an ROE of 31.91%—standing out among peers.
Revenue composition: 66.52% from general patients, 32.63% from social security patients, 0.85% from other income. The group is adjusting billing standards for complex diseases and expanding service areas to meet the growth of international patients, especially in medical tourism. Current stock price is 183 Baht, with a P/E of 18.34.
) Bangkok Medical City ###BDMS(: Internationalization Pioneer
BDMS operates at the largest scale, with a market cap of 355.98 billion Baht and over 5,500 outpatient visits daily. Its unique feature is that international patients account for 67%, while local Thai patients are only 33%. It includes Bangkok Hospital and Ulaanbaatar Hospital in Mongolia.
The group is actively expanding its foreign patient base, increasing bed capacity, and building specialized medical centers. Net profit is 11,654.41 billion Baht, ROE 16.77%, stock price 23.30 Baht, P/E 22.81. Mid- to long-term growth prospects are steady.
) Bangkok Chain Hospital ###BCH(: Scale Expansion Player
BCH owns 15 hospitals and 2 outpatient centers across Bangkok, other provinces, and Laos. Its market value ranks among the top in the healthcare industry. In 2568, net profit is expected to grow by 23%, prompting some analysts to upgrade its rating from “Hold” to “Buy.”
Local patients make up 71%, international patients 29%. Notably, sales of medical products and food increased by 12%, and other income by 14%, indicating a clear trend toward diversified revenue. Stock price is 14.40 Baht, P/E 23.13, ROE 11.88%.
) Chulalongkorn Hospital ###CHG(: Stable Local Expansion
CHG was established in 1986, with registered capital of 110 billion Baht and 12 subsidiaries, totaling 15 hospitals and clinics. The group is expanding branch hospitals and increasing beds to meet surging healthcare demand in growing economic regions.
Revenue sources: outpatient 30.6%, inpatient 34.5%, government welfare programs 35%. Stock price is 2.24 Baht, P/E 20.32, ROE 15.42%, with good financial flexibility.
) Praram 9 Hospital ###PR9(: Digital Medical Innovator
PR9 focuses on the local patient market but also serves patients from China, Myanmar, Laos, Cambodia, and neighboring countries. Founded in 1989, it has invested in modern medical equipment and digital platforms )9 CARE platform and 9 CARE Shop( to improve patient experience.
Revenue structure: 59% outpatient, 41% inpatient. Payment methods: 25% insurance, 68% self-pay, 7% contracted companies. Good relationships with Thai medical education institutions ensure talent reserves. Stock price is 21.30 Baht, P/E 24.47, ROE 13.57.
) Vibhavadi Hospital ###VIBHA(: Local Healthcare Practitioner
VIBHA, established in 1976, is committed to providing affordable healthcare for Thai people. In 2568, performance is expected to grow significantly quarter-over-quarter due to increased beds and new business lines. Some analysts recommend “Buy,” with a target price of 2.74 Baht.
Bed distribution shows regional diversification: 824 in Bangkok, 698 in other provinces, 200 internationally. 45% of revenue from outpatient services, 55% from inpatient. Stock price is 1.88 Baht, P/E 23.85, ROE 8.49%, with room for growth.
) Chularat Health Group ###THG(: Cautiously Watch
THG is positioned as a tertiary medical center, but in 2568, its performance has been volatile. Although it received a 5-star corporate governance rating, the group faces management-related allegations, leading to a rebound in stock price. However, some analysts expect the stock to decline.
Financially, net loss is 30.298 billion Baht, ROE is -6.91%, the only company in the group with negative growth. Stock price is 13.50 Baht. Investors should carefully assess the risks of this stock.
How to Scientifically Choose Hospital Stocks?
) Step 1: Differentiate Market Positioning
Hospital stocks fall into two main camps:
International Patient-Oriented: BH, BDMS, BCH, with revenue mainly from foreign or high-end patients; pay attention to the international economic situation
Local Patient-Oriented: VIBHA, CHG, PR9, THG, benefiting from domestic healthcare demand growth
Step 2: Master Key Financial Indicators
P/E Ratio### Used to evaluate stock value. Among peers, BH’s 18.34 is most attractive, while PR9’s 24.47 is in the overvalued range.
ROE( Return on Shareholders’ Equity) reflects capital efficiency. BH’s 31.91% leads, VIBHA’s 8.49% is lowest. Choosing companies with ROE above 15% offers more long-term profit security.
( Step 3: Assess Growth Strategies
Mergers and Acquisitions: Rapid expansion but with restructuring costs
Organic Expansion: Steady but needs time to verify
Differentiated Services: Such as PR9’s digital medical innovation, BDMS’s medical tourism specialization
Summary: 2568 Year Hospital Stock Investment Roadmap
For long-term investors seeking stable income, ซื้อหุ้นโรงพยาบาล remains a preferred choice for building a defensive portfolio.
If you prefer large-cap stocks with steady growth, BH and BDMS are top picks. For growth potential and value opportunities, CHG and VIBHA offer different prospects. Regardless of choice, the key is to make decisions based on in-depth fundamental analysis, comparison of financial indicators, and understanding operational strategies. Avoid blindly following trends; long-term holding can often mitigate short-term volatility and fully enjoy the growth dividends of the healthcare industry.
Investment Tip: Although healthcare is resilient to downturns, it is not risk-free. Before investing, it is recommended to consult professional analysts and tailor your investment proportion according to your risk tolerance.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
2568 Year Hospital Stock Investment Guide: 7 High-Quality Stocks Worth Watching
Why Do Hospital Stocks Continue to Attract Funds in 2568?
Many investors are re-evaluating the healthcare sector. This is no coincidence—along with the accelerating aging population in Thailand, rising public demand for quality medical services, and the emergence of new diseases, hospital businesses are showing steady growth momentum. Unlike other cyclical industries, ซื้อหุ้นโรงพยาบาล ( purchasing hospital stocks ) has become a key choice for building a defensive investment portfolio.
Three Main Attractions of Hospital Stocks:
Overview Comparison of the Top 7 Hospital Stocks in 2568
In-Depth Analysis of the 7 Hospital Stocks
Bangkok Hospital Group (BH): Market Leader
As one of Thailand’s oldest private hospitals, founded in 1984 (, BH has become a major contractor for social security programs. Latest data shows a market cap of 139,110 billion Baht, net profit of 5,871.77 billion Baht, and an ROE of 31.91%—standing out among peers.
Revenue composition: 66.52% from general patients, 32.63% from social security patients, 0.85% from other income. The group is adjusting billing standards for complex diseases and expanding service areas to meet the growth of international patients, especially in medical tourism. Current stock price is 183 Baht, with a P/E of 18.34.
) Bangkok Medical City ###BDMS(: Internationalization Pioneer
BDMS operates at the largest scale, with a market cap of 355.98 billion Baht and over 5,500 outpatient visits daily. Its unique feature is that international patients account for 67%, while local Thai patients are only 33%. It includes Bangkok Hospital and Ulaanbaatar Hospital in Mongolia.
The group is actively expanding its foreign patient base, increasing bed capacity, and building specialized medical centers. Net profit is 11,654.41 billion Baht, ROE 16.77%, stock price 23.30 Baht, P/E 22.81. Mid- to long-term growth prospects are steady.
) Bangkok Chain Hospital ###BCH(: Scale Expansion Player
BCH owns 15 hospitals and 2 outpatient centers across Bangkok, other provinces, and Laos. Its market value ranks among the top in the healthcare industry. In 2568, net profit is expected to grow by 23%, prompting some analysts to upgrade its rating from “Hold” to “Buy.”
Local patients make up 71%, international patients 29%. Notably, sales of medical products and food increased by 12%, and other income by 14%, indicating a clear trend toward diversified revenue. Stock price is 14.40 Baht, P/E 23.13, ROE 11.88%.
) Chulalongkorn Hospital ###CHG(: Stable Local Expansion
CHG was established in 1986, with registered capital of 110 billion Baht and 12 subsidiaries, totaling 15 hospitals and clinics. The group is expanding branch hospitals and increasing beds to meet surging healthcare demand in growing economic regions.
Revenue sources: outpatient 30.6%, inpatient 34.5%, government welfare programs 35%. Stock price is 2.24 Baht, P/E 20.32, ROE 15.42%, with good financial flexibility.
) Praram 9 Hospital ###PR9(: Digital Medical Innovator
PR9 focuses on the local patient market but also serves patients from China, Myanmar, Laos, Cambodia, and neighboring countries. Founded in 1989, it has invested in modern medical equipment and digital platforms )9 CARE platform and 9 CARE Shop( to improve patient experience.
Revenue structure: 59% outpatient, 41% inpatient. Payment methods: 25% insurance, 68% self-pay, 7% contracted companies. Good relationships with Thai medical education institutions ensure talent reserves. Stock price is 21.30 Baht, P/E 24.47, ROE 13.57.
) Vibhavadi Hospital ###VIBHA(: Local Healthcare Practitioner
VIBHA, established in 1976, is committed to providing affordable healthcare for Thai people. In 2568, performance is expected to grow significantly quarter-over-quarter due to increased beds and new business lines. Some analysts recommend “Buy,” with a target price of 2.74 Baht.
Bed distribution shows regional diversification: 824 in Bangkok, 698 in other provinces, 200 internationally. 45% of revenue from outpatient services, 55% from inpatient. Stock price is 1.88 Baht, P/E 23.85, ROE 8.49%, with room for growth.
) Chularat Health Group ###THG(: Cautiously Watch
THG is positioned as a tertiary medical center, but in 2568, its performance has been volatile. Although it received a 5-star corporate governance rating, the group faces management-related allegations, leading to a rebound in stock price. However, some analysts expect the stock to decline.
Financially, net loss is 30.298 billion Baht, ROE is -6.91%, the only company in the group with negative growth. Stock price is 13.50 Baht. Investors should carefully assess the risks of this stock.
How to Scientifically Choose Hospital Stocks?
) Step 1: Differentiate Market Positioning
Hospital stocks fall into two main camps:
Step 2: Master Key Financial Indicators
P/E Ratio### Used to evaluate stock value. Among peers, BH’s 18.34 is most attractive, while PR9’s 24.47 is in the overvalued range.
ROE( Return on Shareholders’ Equity) reflects capital efficiency. BH’s 31.91% leads, VIBHA’s 8.49% is lowest. Choosing companies with ROE above 15% offers more long-term profit security.
( Step 3: Assess Growth Strategies
Summary: 2568 Year Hospital Stock Investment Roadmap
For long-term investors seeking stable income, ซื้อหุ้นโรงพยาบาล remains a preferred choice for building a defensive portfolio.
If you prefer large-cap stocks with steady growth, BH and BDMS are top picks. For growth potential and value opportunities, CHG and VIBHA offer different prospects. Regardless of choice, the key is to make decisions based on in-depth fundamental analysis, comparison of financial indicators, and understanding operational strategies. Avoid blindly following trends; long-term holding can often mitigate short-term volatility and fully enjoy the growth dividends of the healthcare industry.
Investment Tip: Although healthcare is resilient to downturns, it is not risk-free. Before investing, it is recommended to consult professional analysts and tailor your investment proportion according to your risk tolerance.